Image-guided percutaneous ablation of lung malignancies a minimally invasive alternative for nonsurgical patients or unresectable tumors

Murthy R. Chamarthy, Mohit Gupta, Terence W. Hughes, Noel B. Velasco, Jacob Cynamon, Yosef S. Golowa

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Lung cancer remains the malignancy with the highest mortality and second highest incidence in both men and women within the United States. Imageguided ablative therapies are safe and effective for localized control of unresectable liver, renal, bone, and lung tumors. Local ablative therapies have been shown to slow disease progression and prolong disease-free survival in patients who are not surgical candidates, either due to local extent of disease or medical comorbidities. Commonly encountered complications of percutaneous ablation of lung tumors include pneumothorax, pleural inflammation, pleural effusions, and pneumonia, which are usually easily managed. This review will discuss the merits of image-guided ablation in the treatment of lung tumors and the underlying mechanism, procedural techniques, clinical utility, toxicity, imaging of tumor response, and future developments, with a focus on radiofrequency ablation.

Original languageEnglish (US)
Pages (from-to)68-81
Number of pages14
JournalJournal of Bronchology and Interventional Pulmonology
Volume21
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Lung
Neoplasms
Pneumothorax
Pleural Effusion
Disease-Free Survival
Disease Progression
Comorbidity
Lung Neoplasms
Pneumonia
Therapeutics
Inflammation
Kidney
Bone and Bones
Mortality
Liver
Incidence

Keywords

  • Cryoablation
  • Heat sink
  • Impedance
  • Irreversible electroporation
  • Laser
  • Lung malignancy
  • Microwave
  • Non-small cell lung carcinoma
  • Pneumothorax
  • Radiofrequency ablation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Image-guided percutaneous ablation of lung malignancies a minimally invasive alternative for nonsurgical patients or unresectable tumors. / Chamarthy, Murthy R.; Gupta, Mohit; Hughes, Terence W.; Velasco, Noel B.; Cynamon, Jacob; Golowa, Yosef S.

In: Journal of Bronchology and Interventional Pulmonology, Vol. 21, No. 1, 2014, p. 68-81.

Research output: Contribution to journalArticle

@article{f913541dd5f94d8a8e2a534c47e004e4,
title = "Image-guided percutaneous ablation of lung malignancies a minimally invasive alternative for nonsurgical patients or unresectable tumors",
abstract = "Lung cancer remains the malignancy with the highest mortality and second highest incidence in both men and women within the United States. Imageguided ablative therapies are safe and effective for localized control of unresectable liver, renal, bone, and lung tumors. Local ablative therapies have been shown to slow disease progression and prolong disease-free survival in patients who are not surgical candidates, either due to local extent of disease or medical comorbidities. Commonly encountered complications of percutaneous ablation of lung tumors include pneumothorax, pleural inflammation, pleural effusions, and pneumonia, which are usually easily managed. This review will discuss the merits of image-guided ablation in the treatment of lung tumors and the underlying mechanism, procedural techniques, clinical utility, toxicity, imaging of tumor response, and future developments, with a focus on radiofrequency ablation.",
keywords = "Cryoablation, Heat sink, Impedance, Irreversible electroporation, Laser, Lung malignancy, Microwave, Non-small cell lung carcinoma, Pneumothorax, Radiofrequency ablation",
author = "Chamarthy, {Murthy R.} and Mohit Gupta and Hughes, {Terence W.} and Velasco, {Noel B.} and Jacob Cynamon and Golowa, {Yosef S.}",
year = "2014",
doi = "10.1097/LBR.0000000000000008",
language = "English (US)",
volume = "21",
pages = "68--81",
journal = "Journal of Bronchology and Interventional Pulmonology",
issn = "1944-6586",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Image-guided percutaneous ablation of lung malignancies a minimally invasive alternative for nonsurgical patients or unresectable tumors

AU - Chamarthy, Murthy R.

AU - Gupta, Mohit

AU - Hughes, Terence W.

AU - Velasco, Noel B.

AU - Cynamon, Jacob

AU - Golowa, Yosef S.

PY - 2014

Y1 - 2014

N2 - Lung cancer remains the malignancy with the highest mortality and second highest incidence in both men and women within the United States. Imageguided ablative therapies are safe and effective for localized control of unresectable liver, renal, bone, and lung tumors. Local ablative therapies have been shown to slow disease progression and prolong disease-free survival in patients who are not surgical candidates, either due to local extent of disease or medical comorbidities. Commonly encountered complications of percutaneous ablation of lung tumors include pneumothorax, pleural inflammation, pleural effusions, and pneumonia, which are usually easily managed. This review will discuss the merits of image-guided ablation in the treatment of lung tumors and the underlying mechanism, procedural techniques, clinical utility, toxicity, imaging of tumor response, and future developments, with a focus on radiofrequency ablation.

AB - Lung cancer remains the malignancy with the highest mortality and second highest incidence in both men and women within the United States. Imageguided ablative therapies are safe and effective for localized control of unresectable liver, renal, bone, and lung tumors. Local ablative therapies have been shown to slow disease progression and prolong disease-free survival in patients who are not surgical candidates, either due to local extent of disease or medical comorbidities. Commonly encountered complications of percutaneous ablation of lung tumors include pneumothorax, pleural inflammation, pleural effusions, and pneumonia, which are usually easily managed. This review will discuss the merits of image-guided ablation in the treatment of lung tumors and the underlying mechanism, procedural techniques, clinical utility, toxicity, imaging of tumor response, and future developments, with a focus on radiofrequency ablation.

KW - Cryoablation

KW - Heat sink

KW - Impedance

KW - Irreversible electroporation

KW - Laser

KW - Lung malignancy

KW - Microwave

KW - Non-small cell lung carcinoma

KW - Pneumothorax

KW - Radiofrequency ablation

UR - http://www.scopus.com/inward/record.url?scp=84898754432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898754432&partnerID=8YFLogxK

U2 - 10.1097/LBR.0000000000000008

DO - 10.1097/LBR.0000000000000008

M3 - Article

C2 - 24419192

AN - SCOPUS:84898754432

VL - 21

SP - 68

EP - 81

JO - Journal of Bronchology and Interventional Pulmonology

JF - Journal of Bronchology and Interventional Pulmonology

SN - 1944-6586

IS - 1

ER -